Event Details

Join Immatics at the 3rd Gene and Cell Therapy: Quality Developments to Commercialization Online Summit! Addressing cellular and gene therapy-related developments and manufacturing controls, cell and gene therapies experts and advisers will exchange practical insights and expectation.

Wednesday October 6, 5:35pm - 6:00pm CEST

Presentation: Optimizing manufacturing and logistics for autologous ex vivo T-cell therapies

• Development of TCR-based immunotherapies against novel targets for solid tumours
• Manufacturing, supply chain and logistics during early-stage clinical development for TCR-engineered T-cell products
• Outlook towards late-stage development and commercialization

Presenter: Pinar Cicalese, Director CMC Commercial Strategy Immatics

We are looking forward to (e-)meeting you!

For more information please visit the event's website: 3rd Gene and Cell Therapy: Quality Developments to Commercialization Online Summit